Jakob Loven

Jakob Loven is currently the Director at A2 Biotherapeutics. Prior to this, they were with Flare Therapeutics, Boundless Bio, IconOVir Bio, and Breakthrough Properties. Jakob also spent two years as a Board Member at Kronos Bio, Inc. and Vividion Therapeutics, Inc. In addition, they have also been with Arrakis Therapeutics and Nextech Invest Ltd.

Jakob Loven holds a Doctor of Philosophy (Ph.D.) in Medical Sciences from Karolinska Institutet, a Bachelor's degree in Biomedical Sciences from Anglia Ruskin University, and an International Baccalaureate in Natural Sciences from Sigtunaskolan Humanistiska Läroverket (SSHL).